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Plasmids that carry the Escherichia coli cell shape gene rodA directed the
synthesis of a cytoplasmic membrane protein (Mr, 31,000 [31K protein]) in
minicells, maxicells, and an in vitro-coupled transcription-translation system. The
31K protein was identified as the rodA gene product, because it was not
synthesized from the vector plasmids or from a plasmid in which the rodA gene
was inactivated by insertion of Tn1000. Furthermore, a purified 1.6-kilobase
KpnI-BamHI DNA fragment that contained the intact rodA gene directed the
synthesis of only the 31K protein in an in vitro system. The apparent molecular
weight of the protein was identical whether synthesized in vivo or in vitro,
indicating that the rodA gene product is not made as a preprotein. The direction of
transcription of rodA was from the KpnI site towards the BamHI site. The 31K
protein was unusual in that it could only be detected when cell membranes were
solubilized at low temperature (e.g., 37°C) before sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Apparently the rodA gene product aggregates
after being boiled in sodium dodecyl sulfate and fails to enter a polyacrylamide
gel.
The growth of rod-shaped bacteria requires
the insertion of wall materials to produce cylin-
drical cell surface during cell elongation and
hemispherical surface during cross wall forma-
tion at cell division. Strains that produce fila-
ments or grow as spherical cells should include
mutants defective in gene products required for
the synthesis of the cross wall and the cylindri-
cal wall, respectively. Identification of the gene
products that are defective in spherical mutants
should therefore define the components in-
volved in the initiation and growth of the cylin-
drical portion of the bacterial cell wall.
Mutations that result in the growth of Esche-
richia coli as spherical cells map in either pbpA
or rodA (also called mrdA and mrdB, respective-
ly [24]) at 14 min on the E. coli chromosome (1,
9, 13, 18, 21) or in envB at 70 min (26). pbpA is
the structural gene for penicillin-binding protein
2 (PBP2), which is the killing target for mecil-
linam, a 1-lactam antibiotic that causes spherical
growth of E. coli cells (18). Nothing is known
about the envB gene product. The rodA gene
maps next to pbpA in a small cluster of cell
shape and peptidoglycan biosynthesis genes (20,
21, 24). This cluster also includes the gene (54K
gene) for a cytoplasmic membrane protein (Mr,
54,000 [54K protein]) of unknown function, and
the dacA gene that codes for PBP5, a major D-
alanine carboxypeptidase (20). Although inacti-
vation of PBP5 has no serious effect on cell
morphology, overproduction of PBP5 results in
the growth of E. coli as spherical cells (12).
All four genes are located within a 5.6-kilo-
base (kb) region in the order pbpA-rodA-54K
gene-dacA (21). The rodA and pbpA genes are
probably contiguous, but they are clearly dis-
tinct as shown by complementation analysis (20,
24), deletion mapping, and subcloning (21). They
are also distinguishable by biochemical criteria,
since pbpA mutants have detects in PBP2 pro-
duction, whereas rodA mutants do not (20, 24).
The rodA gene was cloned on both bacteri-
ophage A and plasmid vectors, but attempts to
identify the gene product by phage infection of
UV-irradiated bacteria, minicells, or maxicells
and an in vitro transcription-translation system
were unsuccessful (20, 21; unpublished data).
We show here that the rodA gene product is a
cytoplasmic membrane protein (Mr, 31,000) that
had previously escaped detection because it
aggregates irreversibly when boiled in sodium
dodecyl sulfate (SDS) buffer before gel electro-
phoresis.
MATERIALS AND METHODS
Bacterial strains and plasmids. The E. coli strains
used were: SP5211 rodA52(Ts) his purB proA thi lacY
rpsL (20); SP5211 recA = SP5211 srl::TnlO recA56;
DS410 minA minB; CSR603 phr uvrA6 recAl thr leuB
proA argE thi ara lacY galK mtl tsx supE gyrA rpsL
(17); and RB308 F+ deoC thyA lacY (from Roger
Buxton). Plasmids used were pACYC184 (2), pLG346,
pLG355, and pGWpL1 (21).
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Media and growth conditions were described previ-
ously (20).
Preparation and manipulation of DNA. The prepara-
tion of plasmid DNA and techniques for the manipula-
tion of DNA and transformation were described previ-
ously (20, 22).
Identification of plasmid-encoded gene products.
Minicells were prepared from strain DS410 carrying
appropriate plasmids and labeled with [35S]methionine
(1,500 Ci/mmol; Amersham International) as described
by Reeve (16). The maxicell technique was done as
described by Sancar et al. (17) with strain CSR603.
The synthesis of proteins directed by DNA templates
was performed with an in vitro coupled transcription-
translation system prepared and used as described
previously (14).
Fractionation of cells and analysis of proteins. Cell
envelopes were prepared by sonicating the bacteria,
followed by differential centrifugation, and separated
into cytoplasmic and outer membrane fractions by
extraction with sodium N-lauroyl sarcosinate as de-
scribed previously (19). PBPs were assayed by using
cell envelopes as previously described (19) with
[3H]benzylpenicillin (30 Ci/mmol), which was a gift
from Patrick Cassidy, Merck Laboratories, Rahway,
N.J. SDS-polyacrylamide gel electrophoresis and fluo-
rography were carried out as described previously
(19), except that, where stated, the proteins were
solubilized in SDS sample buffer for 1 h at 37°C rather
than for 5 min at 100°C.
RESULTS
Estimation of rodA gene size. The rodA gene
was cloned on a 1.6-kb KpnI-BamHI fragment
into the low-copy-number plasmid vector
pLG318 to produce pLG346 (21), but no candi-
date for the gene product was found. One possi-
ble reason for this was that the rodA gene
product was very small and difficult to detect
with minicells or maxicells. The size of the rodA
gene was therefore estimated by mapping
TNIOOO insertions (5) that inactivate rodA.
First, a high-copy-number plasmid carrying
rodA was constructed. The 2.6-kb BamHI-Sall
fragment containing the rodA gene was cloned
from pLG346 (21) into the high-copy-number
plasmid vector pACYC184 to produce pLG355
(Fig. 1). Cells carrying pLG355 grew with nor-
mal morphology. E. coli RB308(pLG355) was
then mated with strain SP5211, and transconju-
gants were selected on nutrient agar containing
chloramphenicol (25 ,ug/ml) and streptomycin
(200 ,ug/ml) at 42°C. Most of the colonies that
appeared were large and consisted of rod-shaped
cells owing to complementation of the cell shape
defect of strain SP5211 by the transferred
pLG355:Tn1000 plasmids, but 5.5% were small
colonies consisting of spherical cells produced
by TNIOOO insertions that inactivated the rodA
gene of pLG355. Thirty-one isolates that con-
tained plasmids with insertions of TnJO0O into
the rodA gene were purified, and the plasmid
DNA was prepared. TnJOOO has single cleavage
B C
IpLG355
rodA
FIG. 1. Construction of pLG355. Abbreviations: S,
Sal; K, KpnI; B, BamHI; Cmr, chloramphenicol
resistance.
sites for BamHI and KpnI close to the 8 end (5).
Since the rodA gene lies within a 1.6-kb BamHI-
KpnI fragment, insertions of TnO000 into rodA in
either orientation could be mapped accurately.
The location of the 31 Tn1000 insertions that
inactivated rodA are shown in Fig. 2. Although
some error may be introduced by combining the
two insertion maps, insertions in the same orien-
tation could be compared accurately. Insertions
in orientations 1 and 2 were spread over 1.0 and
0.9 kb, respectively. This provides an estimate
of the size of the rodA gene and indicates that it
could code for a protein with a molecular weight
of up to about 37,000.
Identification of the rodA gene product. As the
rodA gene product was unlikely to be unusually
small, we considered the possibility that it be-
haved abnormally in the SDS-polyacrylamide
0 0.5
kb
Orientation 11(-5)
+
I II I
11 1111 1
KpnI
I I I I I l BamHIKpn Orientation2 (l5-)B
FIG. 2. Location of Tnl000 insertions that inacti-
vate rodA. Each vertical line shows the site of a
Tnl000 insertion that inactivated rodA in the 1.6-kb
KpnI-BamHI fragment of pLG355. Orientations 1 and
2 are the two possible orientations ofTnl000 insertion.
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gel system. Teather et al. (25) reported that the
lactose permease ofE. coli could not be detected
on SDS-polyacrylamide gels when proteins were
solubilized in SDS sample buffer at 100NC be-
cause this treatment irreversibly aggregated the
protein so that it failed to enter the gel. Howev-
er, solubilizing the proteins at 37°C prevented
aggregation, and the permease was identified.
To see whether the rodA gene product also
aggregated after being boiled, we prepared mini-
cells from strain DS410 containing pACYC184,
pLG355 (which carries rodA), or pLG355
rodA::TnJOOO. The proteins synthesized in the
minicells were labeled with [35S]methionine, and
SDS sample buffer was added. Half of each
sample was boiled for 5 min (the standard proce-
dure), and the other half was incubated at 37°C
for 1 h, and the proteins synthesized were ana-
lyzed by SDS-polyacrylamide gel electrophore-
sis and autoradiography. A minor protein (Mr,
31,000 [31K protein]) was synthesized by mini-
cells containing pLG355 and detected in samples
solubilized at 37°C, but not in samples that had
been solubilized at 100°C (Fig. 3). The 31K
protein was not synthesized in minicells carrying
pACYC184 or pLG355 rodA::TNIOOO, strongly
suggesting that it was the rodA gene product.
It is interesting that the tetracycline resistance
protein (Mr, 34,000 [23]) encoded by pACYC184
was visible in greater amounts in samples solubi-
lized at 37°C than in those solubilized at 100°C.
A B C D E F
Tet -
rodA-
CAT- _ _ _ _ _-
4
..
i'W
FIG. 3. Identification of the rodA gene product in
minicells. Minicells were prepared from E. coli DS410
carrying pACYC184 (A and D), pLG355 (B and E), or
pLG344 rodA::Tn1000 (C and F). The plasmid-speci-
fied proteins were labeled with [35S]methionine, sepa-
rated on a 13% SDS-polyacrylamide gel, and detected
by autoradiography. Proteins were solubilized in SDS
sample buffer at 100°C for 5 min (A, B, C) or at 37°C
for 1 h (D, E, F). Tet, Tetracycline resistance protein;
CAT, chloramphenicol acetyltransferase. Molecular
weights (MW) (x 103) are shown to the right.
This protein may also aggregate to some extent
on boiling.
Further evidence that the 31K protein was the
rodA gene product was obtained by purifying the
1.6-kb KpnI-BamHI fragment that contained
rodA and using this as a template for an in vitro
transcription-translation system. A 31K protein
was synthesized and detected in samples solubi-
lized at 37°C, but not in those solubilized at
100°C (Fig. 4).
Cellular location of the rodA gene product.
PBP2, PBP5, and the 54K protein, which are
synthesized from the gene cluster that includes
rodA, are all located in the cytoplasmic mem-
brane (19, 20). It was therefore of interest to
determine the location of the rodA gene product.
As fractionation of minicells is troublesome, the
plasmid-specified proteins were labeled by the
maxicell system (17). The 31K protein was
found exclusively in the cell envelope fraction
and, after extraction of the cell envelopes with
1% sodium lauroyl sarcosinate, was recovered
in the solubilized material, indicating that the
rodA gene product was probably a cytoplasmic
membrane protein (Fig. 5). As expected, the
tetracycline resistance protein, a component of
the cytoplasmic membrane, was also found ex-
clusively in the solubilized material (Fig. 5).
rod4 gene product not made as a preprotein.
Both PBP5 and the 54K protein synthesized
from the gene cluster are made as preproteins
and processed to their mature forms during
insertion into the cytoplasmic membrane (6, 15;
M. Jackson, personal communication). Since
the 31K protein was also a cytoplasmic mem-
brane protein, we examined whether it was
made as a preprotein. The size of the rodA gene
product synthesized in vivo was therefore com-
pared with that of the primary translation prod-
uct synthesized in vitro.
Proteins encoded by pLG355 were labeled
with [35S]methionine in minicells and in an in
vitro transcription-translation system. Cyclic
AMP was omitted from the in vitro system (14)
to decrease transcription from the powerful pro-
moter of the chloramphenicol acetyltransferase
gene present on the plasmids (3). The proteins
were analyzed by SDS-polyacrylamide gel elec-
trophoresis and autoradiography (Fig. 6). No
significant difference could be seen in the appar-
ent molecular weight of the 31K protein synthe-
sized in vivo or in vitro, and the rodA gene
product appeared to enter the cytoplasmic mem-
brane without processing.
rodA gene product not a PBP. The rodA gene
maps between the genes encoding PBP2 and
PBP5 (20). Since the standard assay for PBPs
involves boiling samples in SDS sample buffer
before electrophoresis (19), it was possible that
the rodA gene product was also a PBP that had
J. BACTERIOL.
E. COLI rodA GENE PRODUCT 857
A B C D
MW
-43
rodA-
-30
-14.3
FIG. 4. Synthesis of the rodA gene product in vitro
from a 1.6-kb KpnI-BamHI fragment. pLG355 was
cleaved with KpnI and BamHI, and the 1.6-kb frag-
ment that carries rodA was purified as described
previously (19). A 2-,ug sample of the DNA fragment
was added to an in vitro transcription-translation sys-
tem (14), and the proteins synthesized were labeled
with [35S]methionine, separated on a 15% SDS-poly-
acrylamide gel, and detected by autoradiography.
Samples were solubilized in SDS sample buffer at 100
(lanes A and B) or 37°C (lanes C and D). Lanes A and
C, Controls (no DNA added); lanes B and D, rodA
DNA fragment. Molecular weights (MW) (x103) are
shown to the right.
not been detected previously because of aggre-
gation after boiling. We therefore assayed PBPs
in cell envelopes prepared from several E. coli
K-12 strains with [3H]benzylpenicillin (30 ,ug/lnl)
as described previously (19), except that half of
each sample was not boiled in SDS sample
buffer before electrophoresis on a 12% SDS-
polyacrylamide gel. No new PBP appeared in
the unboiled samples, and we concluded that the
rodA gene product is not a PBP (data not
shown).
Direction of transcription of the rodA gene. The
direction of transcription of rodA was deter-
mined by inserting the gene in both orientations
in front of the powerful phage A leftward pro-
moter (PL) in the temperature-sensitive expres-
sion vector pGWpL1. This plasmid (kindly pro-
vided by Geoff Wilson) is a derivative ofpBR322
that carries the N PL cI857 region from phage A
(21). At 30°C the cI protein shuts off transcrip-
tion, but at 42°C the repressor is inactivated and
transcription occurs from PL.
The rodA gene was cloned on a 2.9-kb Sail
fragment from pLG346 into the unique Sail site
in pGWpL1. The ligation mixture was used to
transform the temperature-sensitive rodA mu-
tant SP5211 recA(XA) to ampicillin resistance
and rod shape at 42°C. Plasmid DNA was isolat-
ed from rod-shaped transformants, and restric-
tion mapping showed that the transformants all
contained the 2.9-kb Sall fragment from pLG346
cloned in the same orientation. This plasmid was
named pLG351. Recombinant plasmids contain-
ing the 2.9-kb Sall fragment in the opposite
orientation would possess a 275-base-pair in-
verted repeat and were presumably not recover-
able (11). The rodA gene was therefore cloned in
the opposite orientation by inserting the 2.6-kb
BamHI-SaII fragment from pLG346 between the
unique BamHI and SalI sites of pGWpL1. The
resulting plasmid was named pLG352.
The level of the rodA gene product synthe-
sized in minicells carrying pLG351 and pLG352
was measured at 30 and 42°C. At 30°C both
plasmids directed the synthesis of the 31K pro-
tein. At 42°C expression from PL resulted in
increased levels of the rodA gene product in
minicells containing pLG351, whereas the level
in minicells containing pLG352 became unde-
tectable. The increased expression from pLG351
A B C D E F
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FIG. 5. Location of the rodA gene product in the
cytoplasmic membrane. Proteins encoded by pA-
CYC194 (lanes A through C) or pLG355 (lanes D
through F) were labeled with [35S]methionine by the
maxicell system (17). A portion of labeled maxicells
was solubilized (lanes A and D), and the remainder
was used to prepare cytoplasmic (lanes B and E) and
outer membrane (lanes C and F) fractions as previous-
ly described (19). The labeled proteins (solubilized at
37°C for 1 h) were analyzed on a 13% SDS-polyacryl-
amide gel, followed by fluorography. A protein with a
mobility slightly faster than the rodA gene product is
visible in lanes A and B. The protein was not always
detected, and it may be a degradation product of the
tetracycline resistance protein.
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at 42°C indicated that the rodA gene was insert-
ed in the correct orientation for transcription
from the strong PL promoter in this plasmid, and
the rodA gene is therefore transcribed from the
KpnI site towards the BamHI site. In the oppo-
site orientation (pLG352), the level of 31K pro-
tein was decreased, presumably owing to an-
tagonistic transcription of rodA from the more
powerful PL promoter.
DISCUSSION
We previously failed to detect the product of
the rodA gene (20). In this paper we identified a
protein (31K protein) encoded by plasmids that
carry the rodA gene by solubilizing proteins at
37 rather than 100°C before electrophoresis.
This protein is believed to be the rodA gene
product, because all of the plasmids that com-
plemented rodA in vivo produced the 31K pro-
tein, but it was not produced by the plasmid
vectors or by a plasmid in which the integrity of
the rodA gene had been destroyed by insertion
of Tnl 000. The size of the protein was consistent
with the size of the gene estimated by mapping
Tn1000 insertions. Furthermore, the 31K protein
was encoded by a 1.6-kb KpnI-BamHI fragment
that was shown genetically to carry rodA (21),
and this purified DNA fragment directed the
synthesis of the 31K protein in an in vitro
transcription-translation system. The amount of
rodA gene product synthesized in minicells,
maxicells, and in vitro was very small, and it is
likely that the level of the protein in vivo is low.
A B
rod A- t 4
CAT - S
FIG. 6. Synthesis of the rodA gene product in vitro
and in vivo. The proteins encoded by pLG355 were
labeled with [35S]methionine in minicells (A) or an in
vitro transcription-translation system (B) and fraction-
ated on a 13% SDS-polyacrylamide gel, followed by
fluorography. CAT, Chloramphenicol acetyltransfer-
ase.
The failure to observe the 31K protein when
samples were boiled in SDS sample buffer was
presumably caused by aggregation of the protein
so that it could not enter the polyacrylamide gel.
Lactose permease (25) and glycerol phosphate
permease (10) are other examples of proteins
that are not detected by the normal procedures
of SDS-polyacrylamide gel electrophoresis be-
cause of protein aggregation after boiling in SDS
sample buffer. The tetracycline resistance pro-
tein (Mr, 34,000) may also aggregate to some
extent after boiling (Fig. 3). It is interesting that
these examples are all cytoplasmic membrane
proteins, but the reasons why these particular
proteins aggregate are unclear.
PBP2, the 54K protein, the 31K protein, and
PBP5 are all cytoplasmic membrane proteins.
Some cytoplasmic membrane proteins of E. coli
are synthesized as preproteins (15), whereas
others are not (4, 7). PBP5 and the 54K protein
were shown to be made as preproteins, as their
primary translation products are larger than the
in vivo forms (6, 15; M. Jackson, personal
communication). With PBP5, DNA sequencing
confirmed the presence of an amino-terminal
signal peptide of 29 residues that is removed
during insertion of the protein into the cytoplas-
mic membrane (J. K. Broome-Smith, A. E.
Edelman, and B. G. Spratt, unpublished data).
The rodA gene product does not appear to be
synthesized as a preprotein, because the size of
the protein made in vitro and in vivo was indis-
tinguishable. It is not yet known whether PBP2
is synthesized as a preprotein.
The rodA gene product is required for the
growth of E. coli as rod-shaped cells, and it
presumably plays an essential role in the synthe-
sis of the cylindrical wall during cell elongation.
The rodA gene maps within a 5.6-kb region that
includes the genes for PBP2, the 54K protein,
and PBP5 (21). The involvement of the rodA
gene product in cell shape, its location in the
cytoplasmic membrane, and the position of the
gene between two genes (pbpA and dacA) that
are known to code for enzymes of peptidoglycan
synthesis make it very likely that the 31K pro-
tein is an enzyme active in the final stages of
peptidoglycan synthesis. At present, however,
nothing is known of its enzymatic activity.
Recently, a peptidoglycan transglycosylase
and a mecillinam-sensitive transpeptidase activi-
ty were detected in cell envelopes prepared from
E. coli cells that produced elevated levels of the
products of the leuS-pbpA-rodA-dacA-lip region
of the chromosome (8). The latter activity was
attributed to PBP2, the only protein known to
interact with mecillinam (18), but the former
activity could be the result of one of the other
products (e.g., the rodA gene product) of the
leuS-lip region. The identification of the rodA
J. BACTERIOL.
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gene product and the construction of overpro-
ducing strains should allow it to be purified and
its enzymatic activity in peptidoglycan synthesis
investigated.
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